Cloopen Group Holding Limited is a software-application business based in the US. Cloopen Group Holding shares (RAAS) are listed on the NYSE and all prices are listed in US Dollars. Cloopen Group Holding employs 1,194 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Cloopen Group Holding
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RAAS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cloopen Group Holding stock price (NYSE: RAAS)Use our graph to track the performance of RAAS stocks over time.
Cloopen Group Holding shares at a glance
|Latest market close||$4.26|
|52-week range||$3.98 - $59.00|
|50-day moving average||$4.58|
|200-day moving average||$7.53|
|Wall St. target price||$11.86|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-11.46|
Buy Cloopen Group Holding shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cloopen Group Holding stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cloopen Group Holding price performance over time
|1 week (2021-10-08)||-0.70%|
|1 month (2021-09-16)||-6.37%|
|3 months (2021-07-16)||-24.47%|
|6 months (2021-04-15)||-62.17%|
|1 year (2020-10-12)||N/A|
|2 years (2019-10-12)||N/A|
|3 years (2018-10-12)||N/A|
|5 years (2016-10-12)||N/A|
Cloopen Group Holding financials
|Revenue TTM||$928.4 million|
|Gross profit TTM||$307 million|
|Return on assets TTM||-12.38%|
|Return on equity TTM||-447.01%|
|Market capitalisation||$705.1 million|
TTM: trailing 12 months
Shorting Cloopen Group Holding shares
There are currently 794,270 Cloopen Group Holding shares held short by investors – that's known as Cloopen Group Holding's "short interest". This figure is 38.6% down from 1.3 million last month.
There are a few different ways that this level of interest in shorting Cloopen Group Holding shares can be evaluated.
Cloopen Group Holding's "short interest ratio" (SIR)
Cloopen Group Holding's "short interest ratio" (SIR) is the quantity of Cloopen Group Holding shares currently shorted divided by the average quantity of Cloopen Group Holding shares traded daily (recently around 2.9 million). Cloopen Group Holding's SIR currently stands at 0.27. In other words for every 100,000 Cloopen Group Holding shares traded daily on the market, roughly 270 shares are currently held short.
To gain some more context, you can compare Cloopen Group Holding's short interest ratio against those of similar companies.
However Cloopen Group Holding's short interest can also be evaluated against the total number of Cloopen Group Holding shares, or, against the total number of tradable Cloopen Group Holding shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cloopen Group Holding's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Cloopen Group Holding shares in existence, roughly 0 shares are currently held short) or 0.0087% of the tradable shares (for every 100,000 tradable Cloopen Group Holding shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cloopen Group Holding.
Find out more about how you can short Cloopen Group Holding stock.
Cloopen Group Holding share dividends
We're not expecting Cloopen Group Holding to pay a dividend over the next 12 months.
You may also wish to consider:
- Cisco Systems (CSCO.US) (2.65% forward annual dividend yield)
Cloopen Group Holding overview
Cloopen Group Holding Limited, through its subsidiaries, provides cloud-based communications solutions in the People's Republic of China. The company offers a suite of cloud-based communications solutions, which include communications platform as a service solution that provides application programing interfaces and software development kits to embed messaging, voice call, audio and video, instant messaging, and other communications into enterprises' applications, services, and/or business processes; cloud-based contact centers, which offers RongCC and 7moor Cloud solutions; and cloud-based unified communications and collaborations, such as RongVideo that provides instant messaging, audio and video conferencing, and telephony solutions. It serves a customer base consisting of enterprises of various industries, including internet, telecommunications, financial services, education, industrial manufacturing, and energy. The company was founded in 2012 and is headquartered in Beijing, China. .
Cloopen Group Holding in the news
Share Buybacks Bring Mixed Results for Smart Share Global, Cloopen
Share Buybacks Bring Mixed Results For Smart Share Global, Cloopen
Cloopen Group Holding Limited Announces up to US$40 Million Share Repurchase Program
Frequently asked questionsWhat percentage of Cloopen Group Holding is owned by institutions?
Currently 7.007% of Cloopen Group Holding shares are held by institutions. How many people work for Cloopen Group Holding?
Latest data suggests 1,194 work at Cloopen Group Holding. When does the fiscal year end for Cloopen Group Holding?
Cloopen Group Holding's fiscal year ends in December. Where is Cloopen Group Holding based?
Cloopen Group Holding's address is: Fairmont Tower, Tower A, Beijing, China What is Cloopen Group Holding's ISIN number?
Cloopen Group Holding's international securities identification number is: US18900M1045
More guides on Finder
How to buy Aura Biosciences (AURA) stock when it goes public
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
How to buy Claros Mortgage Trust (CMTG) stock when it goes public
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
How to buy Evotec SE (EVO) stock when it goes public
Everything we know about the Evotec SE IPO, plus information on how to buy in.
How to buy Delimobil Holding SA (DMOB) stock when it goes public
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
How to buy Blue Water Vaccines (BWV) stock when it goes public
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
How to buy Sonendo (SONX) stock when it goes public
Everything we know about the Sonendo IPO, plus information on how to buy in.
How to buy FlexEnergy Green Solutions (FLXE) stock when it goes public
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
How to buy Stran & Company (STRN) stock when it goes public
Everything we know about the Stran & Company IPO, plus information on how to buy in.
How to buy Kidpik Corp (PIK) stock when it goes public
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
How to buy Nuvectis Pharma (NVCT) stock when it goes public
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
Ask an Expert